Atlas Trials

Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT

Clinical trial NCT04966156 · COMPLETED

Trial details

NCT number
NCT04966156
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Allogeneic DiseaseHematologic CancerCancer Rehabilitation
Start date
2021-09-08
Primary completion
2022-11-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.